4.4 Article

Endoscopic Screening and Risk of Colorectal Cancer according to Type 2 Diabetes Status

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women

Wenjie Ma et al.

Summary: This study examined the association between age at initiation of endoscopy and the risk of colorectal cancer among US women, finding that starting endoscopy before the age of 50 was associated with a reduced risk of colorectal cancer, including cases diagnosed before the age of 55.

JAMA ONCOLOGY (2022)

Article Oncology

Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts

Yang Hu et al.

Summary: This study found that incident type 2 diabetes was associated with higher cancer risk, peaking at around 8 years after the diabetes diagnosis. Similar patterns were observed for plasma C-peptide levels.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Rising incidence of early-onset colorectal cancer - a call to action

Naohiko Akimoto et al.

Summary: The global incidence of early-onset colorectal cancer is on the rise, potentially due to factors such as diet, obesity, lack of exercise, and antibiotic use. Early-onset CRC differs clinically, pathologically, and molecularly from later-onset CRC. Further research spanning childhood and young adulthood is necessary to enhance understanding and management of this disease.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Endocrinology & Metabolism

Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records

Jonathan Pearson-Stuttard et al.

Summary: The study shows a decline in total mortality rates among individuals with diagnosed diabetes between 2001 and 2018, accompanied by a diversification of causes of death, with a significant decrease in vascular disease death rates. Cancers have now become the leading cause of death among individuals with diabetes.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Editorial Material Endocrinology & Metabolism

Cancer overtakes vascular disease as leading cause of excess death associated with diabetes

Mingyang Song

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Oncology

Risk prediction models for colorectal cancer: Evaluating the discrimination due to added biomarkers

Zhe Fang et al.

Summary: Most current risk prediction models for colorectal cancer are based on questionnaires with limited discriminatory ability. This study aimed to incorporate plasma biomarkers to improve the discrimination of these models, showing promising results with an increase in C-statistics after adding selected biomarkers in both male and female populations. The combination of plasma biomarkers and existing risk factors may enhance the performance of risk prediction models for colorectal cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Editorial Material Medicine, General & Internal

US Preventive Services Task Force Recommendations for Colorectal Cancer Screening: Forty-Five Is the New Fifty

Kimmie Ng et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Medicine, General & Internal

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Karina W. Davidson et al.

Summary: Colorectal cancer is a significant cause of cancer-related deaths, with high incidence in adults aged 65 to 74. Screening is recommended for adults aged 50 to 75 with substantial net benefit, for those aged 45 to 49 with moderate net benefit, and selective screening is advised for adults aged 76 to 85.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles

Kai Wang et al.

Summary: The study found that the absolute benefit of colonoscopy screening is over twice as high for individuals with the highest risk profile compared to those with the lowest risk profile. Based on the risk score, individuals with high and low risk profiles may start screening up to 6-7 years earlier and later, respectively, than the recommended age of 45 years.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Medicine, General & Internal

Type 2 diabetes and the risk of colorectal polyps A retrospective nationwide population-based study

Po-Ke Hsu et al.

Summary: The study explores the relationship between Type 2 diabetes mellitus (T2DM) and colorectal polyps, finding that patients with T2DM have a significantly higher probability and risk of developing colorectal polyps. The long-term follow-up results support this conclusion.

MEDICINE (2021)

Article Oncology

Association of Screening Lower Endoscopy With Colorectal Cancer Incidence and Mortality in Adults Older Than 75 Years

Wenjie Ma et al.

Summary: Evidence suggests that screening for colorectal cancer starting at 50 years old can detect early-stage cancer and prevent CRC-related mortality. A prospective cohort study in the US found that screening endoscopy after 75 years old was associated with a lower risk of CRC incidence and CRC-related mortality, supporting the continuation of screening after 75 years old among individuals without significant comorbidities.

JAMA ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Long-Term Incidence and Mortality of Colorectal Cancer After Endoscopic Biopsy With Normal Mucosa: A Swedish-Matched Cohort Study

Mingyang Song et al.

Summary: The study found that a normal colonoscopic biopsy is associated with lower colorectal cancer incidence and mortality, lasting for at least 20 years of follow-up. The results suggest that the screening interval after a normal colonoscopy could potentially be longer than the typically recommended 10 years.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

Type 2 diabetes impacts colorectal adenoma detection in screening colonoscopy

Lorenzo F. Ottaviano et al.

SCIENTIFIC REPORTS (2020)

Review Endocrinology & Metabolism

Young-onset type 2 diabetes mellitus - implications for morbidity and mortality

Dianna J. Magliano et al.

NATURE REVIEWS ENDOCRINOLOGY (2020)

Article Medicine, General & Internal

Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study

Uzair Ali Khan et al.

PLOS MEDICINE (2020)

Article Medicine, General & Internal

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study

Maaike Buskermolen et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Oncology

Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society

Andrew M. D. Wolf et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Editorial Material Gastroenterology & Hepatology

Potential Intended and Unintended Consequences of Recommending Initiation of Colorectal Cancer Screening at Age 45 Years

Peter S. Liang et al.

GASTROENTEROLOGY (2018)

Article Public, Environmental & Occupational Health

Disparities in cancer screening by occupational characteristics

Stacey A. Fedewa et al.

PREVENTIVE MEDICINE (2017)

Article Public, Environmental & Occupational Health

Origin, Methods, and Evolution of the Three Nurses' Health Studies

Ying Bao et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2016)

Review Medicine, General & Internal

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies Modeling Study for the US Preventive Services Task Force

Amy B. Knudsen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Gastroenterology & Hepatology

A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci

Li Hsu et al.

GASTROENTEROLOGY (2015)

Article Medicine, General & Internal

Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012

Linda S. Geiss et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Medicine, General & Internal

Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

Reiko Nishihara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths

Ann G. Zauber et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Medicine, General & Internal

Colorectal cancer screening

M. Bretthauer

JOURNAL OF INTERNAL MEDICINE (2011)

Editorial Material Oncology

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

Article Oncology

Diabetes and Cancer: A Consensus Report

Edward Giovannucci et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2010)

Review Endocrinology & Metabolism

Standards of Medical Care in Diabetes-2010

DIABETES CARE (2010)

Article Gastroenterology & Hepatology

Type 2 diabetes mellitus: The impact on colorectal adenoma risk in women

Jill E. Elwing et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Article Medicine, General & Internal

Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men

FB Hu et al.

ARCHIVES OF INTERNAL MEDICINE (2001)